In a casecontrol study on patients with psoriasis and sex- and age-matched healthy volunteers, psoriatic skins were shown positive oxLDL staining, whereas there was no staining in non-lesional skin samples from the same subject [12]
Industrys fear is that, while this only directly affects Medicare pricing for some drugs, it could have a wider effect on the prices insurance companies are willing to pay in future
The landmark SELECT trial demonstrated that weekly semaglutide 2.4 mg reduces major cardiovascular events by 20% in people with obesity or overweight and established heart diseaseeven in those without diabetes.[1] This finding represents a paradigm shift in cardiovascular prevention, as it's the first time a weight-loss medication has been proven to directly reduce heart attacks, strokes, and cardiovascular deaths
Patients may see them discussed for body composition, sleep, recovery, energy, and healthy aging